ArticleCells2026
Cytotoxic Effect of a β1,4-Galactosyltransferase Inhibitor in Hepatic Carcinoma Cells.
Zhe Dai, Ming Sun, Lihang Chen, Xueqi Fu, Wenfu Yan, Yin Gao, Inka Brockhausen
Abstract read
In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Zhe DaiKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.
Ming SunKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.
Lihang ChenSKL of Marine Food Processing & Safety Control, National Engineering Research Center of Seafood, Collaborative Innovation Center of Seafood Deep Processing, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Xueqi FuKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.
Wenfu YanState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.ORCID 0000-0002-1000-6559 Yin GaoKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.ORCID 0000-0002-0763-0254 Inka BrockhausenDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.
Funding
Jilin Provincial Scientific and Technological Development Program 20240402037GHNational Key R&D Program of China 2021YFA1500403Natural Science and Engineering Council of Canada RGPIN-2022-05389
6 · The paper itselfAbstract
The incidence and mortality of hepatocellular carcinoma (HCC) are increasing worldwide, underscoring the need for novel therapeutic strategies. Synthetic 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-d-glucopyranoside (
Indexed as
Carcinoma, HepatocellularEnzyme InhibitorsGalactosyltransferasesLiver NeoplasmsApoptosisCell Line, TumorCell MovementEndoplasmic Reticulum StressHumansHuman Umbilical Vein Endothelial Cellsbeta1,4-galactosyltransferase, humanEnzyme InhibitorsGalactosyltransferasesanticancer agentscell cycle and apoptosiscytotoxicityβ1,4-galactosyltransferase 1 inhibitor
Identifiers
PMID41677617
PMCPMC12897170
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390